Key Financial Data Of Reporting Company

ONO PHARMACEUTICAL CO., LTD. - Filing #7602299

Concept	As at 2022-03-31	As at 2022-03-31	As at 2022-03-31	As at 2022-03-31	2021-04-01 to 2022-03-31	As at 2021-03-31	2020-04-01 to 2021-03-31	As at 2021-03-31	As at 2020-03-31	As at 2020-03-31	2019-04-01 to 2020-03-31	As at 2019-03-31	As at 2019-03-31	2018-04-01 to 2019-03-31	As at 2018-03-31	As at 2018-03-31	2017-04-01 to 2018-03-31
Key financial data of reporting company
Business results of reporting company
Net sales	—	—	—	—	357,023,000,000 JPY	—	305,183,000,000 JPY	—	—	—	286,235,000,000 JPY	—	—	286,445,000,000 JPY	—	—	260,223,000,000 JPY
Ordinary profit (loss)	—	—	—	—	121,057,000,000 JPY	—	86,778,000,000 JPY	—	—	—	70,773,000,000 JPY	—	—	58,292,000,000 JPY	—	—	47,155,000,000 JPY
Profit (loss)	—	—	—	—	94,594,000,000 JPY	—	76,927,000,000 JPY	—	—	—	69,350,000,000 JPY	—	—	55,732,000,000 JPY	—	—	44,383,000,000 JPY
Share capital	—	17,358,000,000 JPY	—	—	—	—	—	17,358,000,000 JPY	17,358,000,000 JPY	—	—	17,358,000,000 JPY	—	—	17,358,000,000 JPY	—	—
Total number of issued shares	—	528,341,000 xbrli:shares	—	—	—	—	—	528,341,000 xbrli:shares	528,341,000 xbrli:shares	—	—	543,341,000 xbrli:shares	—	—	543,341,000 xbrli:shares	—	—
Net assets	—	599,192,000,000 JPY	—	—	—	—	—	574,566,000,000 JPY	507,735,000,000 JPY	—	—	507,061,000,000 JPY	—	—	477,274,000,000 JPY	—	—
Total assets	—	661,885,000,000 JPY	—	—	—	—	—	669,633,000,000 JPY	599,412,000,000 JPY	—	—	591,395,000,000 JPY	—	—	551,165,000,000 JPY	—	—
Net assets per share	—	1,226.79	—	—	—	—	—	1,150.68	1,016.83	—	—	985.91	—	—	928.03	—	—
Dividend paid per share	—	—	—	—	56.00	—	50.00	—	—	—	45.00	—	—	45.00	—	—	45.00
Interim dividend paid per share	—	—	—	—	28.00	—	22.50	—	—	—	22.50	—	—	22.50	—	—	25.00
Basic earnings (loss) per share	—	—	—	—	190.51	—	154.10	—	—	—	137.59	—	—	108.39	—	—	85.61
Diluted earnings per share	—	—	—	—	190.49	—	154.08	—	—	—	137.57	—	—	108.38	—	—	85.60
Equity-to-asset ratio	—	0.905 xbrli:pure	—	—	—	—	—	0.858 xbrli:pure	0.847 xbrli:pure	—	—	0.857 xbrli:pure	—	—	0.866 xbrli:pure	—	—
Rate of return on equity	—	—	—	—	0.161 xbrli:pure	—	0.142 xbrli:pure	—	—	—	0.137 xbrli:pure	—	—	0.113 xbrli:pure	—	—	0.093 xbrli:pure
Price-earnings ratio	—	—	—	—	16.1 xbrli:pure	—	18.8 xbrli:pure	—	—	—	18.1 xbrli:pure	—	—	20.0 xbrli:pure	—	—	38.5 xbrli:pure
Payout ratio	—	—	—	—	0.294 xbrli:pure	—	0.324 xbrli:pure	—	—	—	0.327 xbrli:pure	—	—	0.415 xbrli:pure	—	—	0.526 xbrli:pure
Number of employees	3,354 xbrli:pure	3,354 xbrli:pure	3,687 xbrli:pure	3,687 xbrli:pure	—	3,607 xbrli:pure	—	3,319 xbrli:pure	3,287 xbrli:pure	3,560 xbrli:pure	—	3,284 xbrli:pure	3,555 xbrli:pure	—	3,199 xbrli:pure	3,480 xbrli:pure	—
Total shareholder return	—	1.435 xbrli:pure	—	—	—	—	—	1.334 xbrli:pure	1.137 xbrli:pure	—	—	0.980 xbrli:pure	—	—	1.449 xbrli:pure	—	—
Total return on share price index	—	1.443 xbrli:pure	—	—	—	—	—	1.415 xbrli:pure	0.996 xbrli:pure	—	—	1.100 xbrli:pure	—	—	1.159 xbrli:pure	—	—